⌘K

Login Start Free

Home/Filings/4/0001447348-15-000032

4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001447348-15-000032

CIK 0000835887operating

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 3:39 PM ET

Size

5.0 KB

Accession

0001447348-15-000032

Insider Transaction Report

Form 4

Period: 2015-06-10

PROGENICS PHARMACEUTICALS INCPGNX

Chief Executive Officer/CSO10% Owner

Transactions

Award
Non-Qualified Stock Option (right to buy)
2015-06-10$6.72/sh+20,000$134,400→ 20,000 total
Exercise: $6.72From: 2015-06-10Exp: 2025-06-10→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable immediately, on the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000835887

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 3:39 PM ET
Size: 5.0 KB

View on SEC.gov